Methods for measuring myeloperoxidase activity toward assessing inhibitor efficacy in living systems

Jiansheng Huang1, Amber Milton1, Robert D Arnold1

  • 1*Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, Alabama, USA Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA.

Insights

Myeloperoxidase (MPO) is crucial for pathogen clearance. This review explores methods to measure MPO activity and oxidant species, aiding in developing MPO inhibitors for inflammatory diseases.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Myeloperoxidase (MPO) is a key enzyme in innate immunity, generating oxidants to eliminate engulfed pathogens.
  • Dysregulated MPO activity is implicated in chronic inflammatory diseases like COPD and rheumatoid arthritis.

Purpose of the Study:

  • To review in vitro and in vivo methods for evaluating MPO function and oxidant generation.
  • To discuss optical imaging probes for monitoring MPO-derived oxidants and MPO accumulation at inflammation sites.
  • To assess the utility of these methods for developing MPO inhibitors.

Main Methods:

  • Evaluation of in vitro assays for MPO activity and inhibition.
  • Monitoring of oxidant species generation during inflammation.
  • Review of optical imaging probes targeting reactive oxygen and nitrogen species.
  • Assessment of preclinical imaging options for MPO in mouse models.

Main Results:

  • Several strategies exist for evaluating MPO function and inhibition in vitro.
  • Optical probes can monitor MPO-derived oxidants, but pharmacokinetic limitations may restrict in vivo use.
  • Preclinical imaging methods allow visualization of MPO accumulation at inflammatory sites.

Conclusions:

  • Accurate measurement of MPO activity and associated oxidants is vital for understanding inflammatory processes.
  • Current imaging probes and assays offer insights but require careful consideration of limitations for in vivo application.
  • Developing safe MPO inhibitors holds promise for treating chronic inflammatory conditions.

Related Concept Videos